Impact on Novartis stock price by end of 2024 | Categorical | | | 8 months ago | |
Novartis achieves clinical milestone with Mariana's drug by May 2024? | Binary | | | 8 months ago | |
Regulatory setback for Novartis/Mariana by May 2024? | Binary | | | 8 months ago | |
Most progress in cancer treatment by Novartis/Mariana by end of 2024 | Categorical | | | 8 months ago | |
Integration status of Mariana Oncology into Novartis by May 2024 | Categorical | | | 8 months ago | |
Will GRO Biosciences secure another funding round by July 19, 2025? | Binary | | | 5 months ago | |
What will be the valuation of GRO Biosciences by end of 2024? | Categorical | | | 5 months ago | |
Will GRO Biosciences announce a major pharmaceutical partnership by end of 2024? | Binary | | | 5 months ago | |
Novartis increases market share in radiopharmaceuticals by end of 2024? | Binary | | | 8 months ago | |
What will be the outcome of GRO Biosciences' lead NSAA-based therapy preclinical trials by end of 2024? | Categorical | | | 5 months ago | |
How many new NSAA-based therapies will GRO Biosciences add to its pipeline by July 19, 2025? | Categorical | | | 5 months ago | |
Will GRO Biosciences initiate a clinical trial for NSAA-based therapy by end of 2024? | Binary | | | 5 months ago | |
